NCT00803166

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Bioequivalence of Three Halobetasol Propionate 0.05% Topical Creams

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 60 (actual)
• Sponsor: Padagis LLC · Industry
• Sex: Female
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Halobetasol Propionate 0.05% Cream in healthy, female subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Halobetasol Propionate 0.05% Cream-Reference Product	Small amount applied and evaluated over the course of three days
DRUG	Halobetasol Propionate 0.05% Cream-Test product 1	Small amount applied and evaluated over the course of three days
DRUG	Halobetasol Propionate 0.05% Cream-Test Product 2	Small amount applied and evaluated over the course of three days

Timeline

• Start date: 2004-01-01
• Primary completion: 2004-01-01
• Completion: 2004-01-01
• First posted: 2008-12-05
• Last updated: 2021-10-18